Aarti Pharmalabs Ltd vs Alembic Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 701.05 as of 18 May 15:30 . The P/E Ratio of Aarti Pharmalabs Ltd changed from 12.9 on March 2023 to 24.9 on March 2025 . This represents a CAGR of 24.51% over 3 yearsThe P/E Ratio of Alembic Pharmaceuticals Ltd changed from 16.5 on March 2021 to 31.3 on March 2025 . This represents a CAGR of 13.66% over 5 years The Market Cap of Aarti Pharmalabs Ltd changed from ₹ 2489 crore on March 2023 to ₹ 6784 crore on March 2025 . This represents a CAGR of 39.69% over 3 yearsThe Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 18971 crore on March 2021 to ₹ 18265 crore on March 2025 . This represents a CAGR of -0.76% over 5 years The revenue of Aarti Pharmalabs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 436.83 crore. This represent the decline of -100% The revenue of Alembic Pharmaceuticals Ltd for the Mar '26 is ₹ 1874 crore as compare to the Dec '25 revenue of ₹ 1891 crore. This represent the decline of -0.92% The ebitda of Aarti Pharmalabs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 104.07 crore. This represent the decline of -100% The ebitda of Alembic Pharmaceuticals Ltd for the Mar '26 is ₹ 229.77 crore as compare to the Dec '25 ebitda of ₹ 264.93 crore. This represent the decline of -13.27% The net profit of Aarti Pharmalabs Ltd changed from ₹ 55.45 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 134.54 crore to ₹ 201.53 crore over 8 quarters. This represents a CAGR of 22.39% The Dividend Payout of Aarti Pharmalabs Ltd changed from 10.55 % on March 2023 to 17.61 % on March 2025 . This represents a CAGR of 18.62% over 3 yearsThe Dividend Payout of Alembic Pharmaceuticals Ltd changed from 25.09 % on March 2021 to 42.97 % on March 2025 . This represents a CAGR of 11.36% over 5 years .

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019.
The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022.
Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India.
It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.

About Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Limited manufactures and markets generic pharmaceutical products all over the world.
The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited.
The company is engaged in pharmaceuticals business.
As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010. In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

FAQs for the comparison of Aarti Pharmalabs Ltd and Alembic Pharmaceuticals Ltd

Which company has a larger market capitalization, Aarti Pharmalabs Ltd or Alembic Pharmaceuticals Ltd?

Market cap of Aarti Pharmalabs Ltd is 6,355 Cr while Market cap of Alembic Pharmaceuticals Ltd is 14,230 Cr

What are the key factors driving the stock performance of Aarti Pharmalabs Ltd and Alembic Pharmaceuticals Ltd?

The stock performance of Aarti Pharmalabs Ltd and Alembic Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Pharmalabs Ltd and Alembic Pharmaceuticals Ltd?

As of May 18, 2026, the Aarti Pharmalabs Ltd stock price is INR ₹701.05. On the other hand, Alembic Pharmaceuticals Ltd stock price is INR ₹723.95.

How do dividend payouts of Aarti Pharmalabs Ltd and Alembic Pharmaceuticals Ltd compare?

To compare the dividend payouts of Aarti Pharmalabs Ltd and Alembic Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.